RE: Trevor’s tweet5 May 2020 18:26
Trevor is CEO of Braveheart and IQAI. Braveheart investee company Sentinel Medical are working with Aptamer group to assess how the use of aptamers can be applied to a point of care test device for Covid19 - check out RNS from 14th April